← Dashboard
Stock
ZEPP
ZEPP HEALTH CORPLatest close $113 of 27 marquee funds currently hold2 CUSIPs mapped
Current holders
3
27 funds tracked
Ever held
5
Current + past
New this quarter
0
Exited this quarter
0
Marquee-fund ownership over time
Aug 9, 2024Nov 14, 2024Nov 14, 2025Feb 17, 2026
Now
3
Current holders
Sorted by tenure (longest first)| Fund | First disclosed | Held | Entry price | Latest close | Return on entry |
|---|---|---|---|---|---|
| Millennium Management | Q4 2025(8Q snapshot) | 2Q | $24 | $11 | -56% |
| Two Sigma Investments | Q1 2026(8Q snapshot) | 1Q | $24 | $11 | -55% |
| Point72 Asset Management | Q1 2026(8Q snapshot) | 1Q | $24 | $11 | -55% |
“Return on entry” is the price-only move from the fund's first disclosure to today — it ignores any adds, trims, or dividends. A fund that built its position over multiple quarters has a true cost basis somewhere between entry price and latest close; this figure is the upper bound.
Past holders
Funds that exited at some point| Fund | Last entry | Exited | Entry → Exit | Return |
|---|---|---|---|---|
| Renaissance Technologies 2× in & out | Q4 2024 | Q1 2026 | → $24 | +682% |
| Citadel Advisors 3× in & out | Q3 2025 | Q4 2025 | → $24 | -32% |
Fundamentals
XBRL · ZEPP HEALTH CORPAnnual figures sourced directly from ZEPP HEALTH CORP's 10-K / 10-Q filings via SEC EDGAR XBRL. Latest fiscal year and the year-over-year change, with up to ten years of history.
Revenue
$258.9M
FY2025+42% YoY
Net income
-$40.07M
FY2025+47% YoY
EPS (diluted)
$-0.1600
FY2025+45% YoY
Free cash flow(?)
-$26.21M
FY2025-2% YoY
Recent SEC filings
10-K · 10-Q · 8-K · 13D/G · proxyThe most recent material filings for Zepp Health Corp — earnings, material events, ownership disclosures, proxy statements. Form 4 insider activity is shown in the panel above.
- 6-KFORM 6-KJun 9, 2026
- 20-FAnnual report (foreign)Apr 24, 2026
- 6-KFORM 6-KMar 16, 2026
- 6-KFORM 6-KNov 5, 2025
- 6-KFORM 6-KAug 4, 2025
- 20-F/AFORM 20-F/AMay 21, 2025
- 6-KFORM 6-KMay 20, 2025
- 20-FAnnual report (foreign)Apr 25, 2025
- 6-KFORM 6-KMar 27, 2025
- 6-KFORM 6-KNov 19, 2024
- SC 13G/A5%+ ownership (amended)Nov 12, 2024
- SC 13G/A5%+ ownership (amended)Oct 4, 2024
- SC 13G/A5%+ ownership (amended)Oct 4, 2024
- 6-KFORM 6-KOct 4, 2024
- 6-KFORM 6-KSep 6, 2024
Trade history
Every open→close lifecycle across tracked funds| Fund | Open date | Close date | Open price | Close price / current | Return |
|---|---|---|---|---|---|
| Two Sigma Investments | Q1 2026 | open | $24 | $11 | -55% |
| Point72 Asset Management | Q1 2026 | open | $24 | $11 | -55% |
| Millennium Management | Q4 2025 | open | $24 | $11 | -56% |
| Citadel Advisors | Q3 2025 | Q4 2025 | $35 | $24 | -32% |
| Citadel Advisors | Q4 2024 | Q1 2025 | $3.39 | $3.03 | -11% |
| Renaissance Technologies | Q4 2024 | Q1 2026 | $3.11 | $24 | +682% |
| Citadel Advisors | Q3 2024 | Q4 2024 | $0.00 | — | +0% |
| Renaissance Technologies | Q3 2024 | Q4 2024 | $0.00 | — | +0% |
Caveats
- Covers only the 27 marquee funds tracked here, not the full institutional universe. A “0 holders” reading does not mean unowned.
- Heavy funds (Renaissance Technologies, Citadel Advisors, Soros Fund Management, Two Sigma Investments, D.E. Shaw, AQR Capital Management, Millennium Management, Point72 Asset Management) use 8-quarter snapshots, so their pre-2024 history is missing.
- “Current” reflects each fund's most recent 13F — filings lag the actual trade by up to 45 days; positions shown may have changed since.
- Cost = price at the entry filing date. Re-entered positions show the most recent open lot.
- Options, ADRs, and unmapped CUSIPs are excluded from the follower-backtest pipeline that produces these snapshots, so certain holding types won't appear here.